News
Growth Drivers include demand for protein-based drugs, rise in chronic disease prevalence, precision medicine expansion, biotech advancements, and AI-driven design tools.Dublin, April 14, 2025 (GLOBE ...
NEW YORK, NY / ACCESS Newswire / April 13, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, ...
Merck & Co. Inc. closed 41.19% below its 52-week high of $134.63, which the company reached on June 25th.
Patient Chart Dynamixâ„¢ is an independent, data-driven service that unveils real-world patient management trends via large-scale patient chart audits. Designed to quantify practice patterns, measure ...
Leaders at Merck & Co. Inc. are facing a new derivative shareholder lawsuit over allegations that they made misleading ...
DelveInsight's Merkel Cell Carcinoma Market Insights report includes a comprehensive understanding of current treatment practices, Merkel cell carcinoma emerging drugs, market share of individual ...
Semarion's SemaCyte® technology transforms adherent cell assays, enabling faster, automated workflows that enhance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results